Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3497312 | 0.80 | PYGL (0.34) | PYGL | |
| SCHEMBL5544528 | 0.74 | — | — | |
| SCHEMBL2508912 | 0.74 | — | — | |
| SCHEMBL3810104 | 0.73 | PYGL (0.39) | PYGL | |
| SCHEMBL2512298 | 0.72 | — | — | |
| SCHEMBL4658991 | 0.70 | — | — | |
| SCHEMBL8332561 | 0.70 | PYGL (0.61) | PYGL | |
| SCHEMBL1814865 | 0.70 | PYGL (0.61) | PYGL | |
| SCHEMBL10696530 | 0.68 | CHRNB2 (0.30) | — | |
| SCHEMBL10880823 | 0.66 | IMPDH2 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4251745-A1 | GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS | Acies Bio d.o.o. (SI) | 2023-10-04 | — | — | EP | disclosed |
| WO-2022112509-A1 | GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS | ACIES BIO D.O.O. (SI) | 2022-06-02 | — | — | WO | disclosed |
| EP-3519582-A1 | METHODS FOR DECOUPLING CELL GROWTH FROM PRODUCTION OF BIOCHEMICALS AND RECOMBINANT POLYPEPTIDES | Danmarks Tekniske Universitet (DK) | 2019-08-07 | — | — | EP | disclosed |
| WO-2018020012-A1 | METHODS FOR DECOUPLING CELL GROWTH FROM PRODUCTION OF BIOCHEMICALS AND RECOMBINANT POLYPEPTIDES | DANMARKS TEKNISKE UNIVERSITET (DK) | 2018-02-01 | — | — | WO | disclosed |
| EP-2401696-A1 | MAMMALIAN CELL LINE MODELS AND RELATED METHODS | GT Life Sciences, Inc. (US) | 2012-01-04 | — | — | EP | disclosed |
| WO-2010098865-A1 | MAMMALIAN CELL LINE MODELS AND RELATED METHODS | GT LIFE SCIENCES, INC. (US) | 2010-09-02 | — | — | WO | disclosed |
| WO-2009052186-A1 | METABOLOMICS-BASED IDENTIFICATION OF DISEASE-CAUSING AGENTS | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| EP-1490678-A4 | COMPOSITIONS AND METHODS FOR MODELING BACILLUS SUBTILIS METABOLISM | GENOMATICA INC (US) | 2007-01-03 | — | — | EP | disclosed |
| EP-1076566-A4 | ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN | UNIV MARYLAND (US) | 2005-01-05 | — | — | EP | disclosed |
| EP-1490678-A2 | COMPOSITIONS AND METHODS FOR MODELING BACILLUS SUBTILIS METABOLISM | Genomatica, Inc. (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003081207-A2 | COMPOSITIONS AND METHODS FOR MODELING BACILLUS SUBTILIS METABOLISM | GENOMATICA, INC. (US) | 2003-10-02 | — | — | WO | disclosed |
| EP-1076566-A1 | ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN | THE UNIVERSITY OF MARYLAND AT BALTIMORE (US) | 2001-02-21 | — | — | EP | disclosed |
| WO-1999058146-A1 | ATTENUATED MUTANTS OF SALMONELLA WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 1999-11-18 | — | — | WO | disclosed |
| WO-1997037685-A1 | GUA MUTANTS OF SHIGELLA spp. AND VACCINES CONTAINING THE SAME | UNIVERSITY OF MARYLAND AT BALTIMORE (US) | 1997-10-16 | — | — | WO | disclosed |